Search clinical trials for: Lapatinib plus trastuzumab
Total 7211 results
-
Berufsverband Niedergelassener Gynäkologischer...OnkoDataMed GmbHWithdrawnMetastatic Breast CancerGermany
-
Boehringer IngelheimCompletedBreast NeoplasmsUnited States, Brazil, Colombia, Peru
-
European Organisation for Research and Treatment...GlaxoSmithKlineCompletedBreast CancerFrance, United Kingdom, Belgium, Switzerland, Slovenia
-
Azienda Ospedaliera Ordine Mauriziano di TorinoUnknownMetastatic Breast CancerItaly
-
Jonsson Comprehensive Cancer CenterGlaxoSmithKlineCompletedBreast CancerUnited States
-
Fudan UniversityCompleted
-
Merrimack PharmaceuticalsCompletedHER-2 Gene AmplificationUnited States
-
Novartis PharmaceuticalsCompletedMetastases, BrainSpain, Hungary, Poland, Germany, Italy, Russian Federation, Sweden, United Kingdom, Thailand, United States, Belgium, France, Greece, Denmark
-
Fudan UniversityRecruitingMetastatic Breast Cancer | HER2-positive Breast CancerChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHER2-positive Breast Cancer | Early-stage Breast Cancer | Adjuvant Treatment After Trastuzumab | RCB Classification 1-2 | NeratiniChina
-
Cancer Trials IrelandCompleted
-
Peking UniversityJiangsu HengRui Medicine Co., Ltd.Recruiting
-
Lei LiCompletedChemotherapy | Recurrent Cervical Carcinoma | Apatinib | Targeted Therapy | Persistent Advanced Cervical Carcinoma | Vascular Endothelial Growth Factor 2 InhibitorChina
-
Fondazione del Piemonte per l'OncologiaUnknown
-
Institute of Cancer Research, United KingdomNovartis; Cancer Research UK; Manchester University NHS Foundation Trust; University...Active, not recruitingBreast CancerUnited Kingdom
-
Novartis PharmaceuticalsTerminatedNeoplasms, BreastBelgium, United States
-
Peking Union Medical College HospitalJiangsu HengRui Medicine Co., Ltd.RecruitingGestational Trophoblastic NeoplasiaChina
-
Novartis PharmaceuticalsTerminatedNeoplasms, BreastUnited States, France, Ireland
-
Boehringer IngelheimCompletedStomach Neoplasms | Breast NeoplasmsFrance
-
Samsung Bioepis Co., Ltd.CompletedHER2 Positive Early or Locally Advanced Breast CancerCzechia
-
Jiangsu HengRui Medicine Co., Ltd.UnknownHER2 Positive Metastatic Breast CancerChina
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Translational Oncology Research InternationalNational Cancer Institute (NCI); University of California, Los AngelesCompleted
-
Shanghai Zhongshan HospitalCompleted
-
PfizerCompleted
-
Byondis B.V.CompletedMetastatic Breast CancerFrance, United States, United Kingdom, Belgium, Spain, Italy, Singapore, Denmark, Sweden, Canada, Netherlands
-
Novartis PharmaceuticalsNCIC Clinical Trials GroupCompletedBreast CancerUnited States, Belgium, Canada, United Kingdom, Argentina, Australia, France, Germany, Israel, Italy, Japan, Netherlands, Poland, Russian Federation, Spain, Taiwan, Thailand, India, Korea, Republic of, Mexico, Ukraine
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer (MBC) | Locally Advance Breast Cancer (LABC)United Kingdom, Spain
-
Novartis PharmaceuticalsCompletedNeoplasms, BreastUnited States
-
Peking University Cancer Hospital & InstituteRecruitingUnresectable Hepatocellular CarcinomaChina
-
Fudan UniversityNot yet recruiting
-
Peking Union Medical College HospitalTaizhou EOC Pharma Co., Ltd.UnknownHER2-positive Breast CancerChina
-
Wuhan Union Hospital, ChinaWithdrawnColorectal Cancer | Chemotherapy | Angiogenesis
-
National Cancer Institute (NCI)Active, not recruitingMale Breast Carcinoma | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States, Puerto Rico
-
Mayo ClinicNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
West German Study GroupGlaxoSmithKlineTerminatedCarcinoma, Ductal, BreastGermany
-
National Cancer Institute (NCI)TerminatedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIC Breast Cancer | Adenocarcinoma of the Gastroesophageal Junction | Recurrent Breast Cancer | Stage IV Gastric Cancer | Recurrent Gastric Cancer | Recurrent Esophageal Cancer | Stage IV Esophageal Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
UNC Lineberger Comprehensive Cancer CenterGlaxoSmithKline; Genentech, Inc.; Susan G. Komen Breast Cancer FoundationCompleted
-
Washington University School of MedicineWithdrawn
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Korea, Republic of, Spain
-
M.D. Anderson Cancer CenterCompleted
-
GlaxoSmithKlineCompleted
-
Henan Cancer HospitalRecruitingCamrelizumab Plus Apatinib as Maintenance Therapy in Extensive-stage Small-cell Lung Cancer (CAMERA)Small Cell Lung CarcinomaChina
-
Shanghai Zhongshan HospitalUnknownGastric Cancer | Chemotherapy Effect | Chemotherapeutic ToxicityChina
-
Henan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.Unknown
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Boehringer IngelheimCompletedLung Cancer | Non-small Cell Lung Cancer (NSCLC)United States
-
Nancy Lin, MDGlaxoSmithKline; NovartisActive, not recruitingBreast CancerUnited States
-
Biocon Biologics UK LtdNot yet recruitingHR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients